Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing: earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures gives cross-border investors faster access to Tokyo-listed disclosures.
This corporate disclosure from SanBio Company Limited was processed by Pulse News Wire on June 15, 2026. It represents a primary source document for Japanese Earnings sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
TOKYO, Jun 15 (Pulse News Wire) – Sanbio Company Ltd. (4592.T) reported consolidated results for Q1 FY2027 (ending January 2027). Revenue was ¥400 million. operating profit was -¥5,229 million. net pr
View all SanBio Company Limited disclosures →
SanBio Company Limited [4592.T]
TOKYO, Jun 15 (Pulse News Wire) – Sanbio Company Ltd. (4592.T) reported consolidated results for Q1 FY2027 (ending January 2027).
Revenue was ¥400 million. operating profit was -¥5,229 million.
Net profit was -¥5,133 million. Total assets stood at ¥14.5 billion with an equity ratio of 85.5%.
The full-year forecast for the current fiscal year is revenue of ¥400 million.
🟢 Confidence: High AI-translated content.